These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


253 related items for PubMed ID: 2606549

  • 1. Interrelationship between bronchoalveolar lavage cellular constituents and pulmonary functions in sarcoidosis.
    Sharma SK, Pande JN, Verma K, Guleria JS.
    Indian J Chest Dis Allied Sci; 1989; 31(2):77-84. PubMed ID: 2606549
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Elevated levels of tryptase in bronchoalveolar lavage fluid from patients with sarcoidosis.
    Eklund A, van Hage-Hamsten M, Sköld CM, Johansson SG.
    Sarcoidosis; 1993 Mar; 10(1):12-7. PubMed ID: 8134709
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Cell count and immunoglobulin level in the bronchoalveolar lavage fluid (BALF) in patients with sarcoidosis].
    Oklek K, Ziora D, Niepsuj G, Jastrzebski D.
    Pneumonol Pol; 1990 Jan; 58(1):17-25. PubMed ID: 2326224
    [Abstract] [Full Text] [Related]

  • 10. TH1/TH2 and TC1/TC2 profiles in peripheral blood and bronchoalveolar lavage fluid cells in pulmonary sarcoidosis.
    Inui N, Chida K, Suda T, Nakamura H.
    J Allergy Clin Immunol; 2001 Feb; 107(2):337-44. PubMed ID: 11174202
    [Abstract] [Full Text] [Related]

  • 11. BAL lymphocyte activation antigens and diffusing capacity are related in mild to moderate pulmonary sarcoidosis.
    Xaubet A, Agustí C, Roca J, Picado C, Rodriguez-Roisin R.
    Eur Respir J; 1993 May; 6(5):715-8. PubMed ID: 8519382
    [Abstract] [Full Text] [Related]

  • 12. Levels of cytokeratin 19 fragments in bronchoalveolar lavage fluid correlate to the intensity of neutrophil and eosinophil-alveolitis in patients with idiopathic pulmonary fibrosis.
    Inage M, Nakamura H, Kato S, Saito H, Abe S, Hino T, Tomoike H.
    Respir Med; 2000 Feb; 94(2):155-60. PubMed ID: 10714422
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Bronchoalveolar lavage fluid (BALF) analysis in interstitial lung diseases--a 7-year experience.
    Sharma SK, Pande JN, Verma K, Guleria JS.
    Indian J Chest Dis Allied Sci; 1989 Feb; 31(3):187-96. PubMed ID: 2638654
    [Abstract] [Full Text] [Related]

  • 16. [The response of alveolar lymphocytes induced by Propionibacterium acnes in pulmonary sarcoidosis: correlation with clinical studies, pulmonary function studies and bronchoalveolar lavage].
    Nakata Y, Kataoka M, Ejiri T, Mori Y, Hioka T, Maeda T, Hosoya S, Ohnoshi T, Kimura I.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1989 Jul; 27(7):837-41. PubMed ID: 2810973
    [Abstract] [Full Text] [Related]

  • 17. Hyaluronate in bronchoalveolar lavage fluid in sarcoidosis and its relationship to alveolar cell populations.
    Eklund A, Hällgren R, Blaschke E, Engström-Laurent A, Persson U, Svane B.
    Eur J Respir Dis; 1987 Jul; 71(1):30-6. PubMed ID: 2820777
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cellular components of the bronchoalveolar lavage correlate with lung function impairment and extrapulmonary involvement markers in active sarcoidosis.
    Chorostowska-Wynimko J, Leśniewska-Radomska D, Krychniak-Soszka A, Remiszewski P, Szopiński J, Wesołowski S, Kuś J, Skopińska-Rózewska E.
    J Physiol Pharmacol; 2004 Sep; 55 Suppl 3():41-7. PubMed ID: 15611592
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.